To better understand emerging technologies, NEVER members Konrad, Anemone, Emil, Arthur, and Joel outline the evolution of the risk landscape around emerging disruptive technologies and draw parallels between the dangers posed by nuclear weapons and those posed by novel biotechnologies. They explore the broader challenge of governing emerging technologies and suggest potential ways forward.
NEVER members gathered for a roundtable discussion of AI and its role in aggravating existential risks.
Nicholas Moulios, from the ELN’s New European Voices on Existential Risk (NEVER) Network, has written the ELN’s first commentary as part of this project. He explores the capabilities of OSINT systems for assessing and mitigating potential nuclear disasters, and how these emerging technologies can be harnessed to improve existential risk resilience in Europe and beyond.
Ahead of the 2023 NPT Preparatory Committee, this policy brief examines how nuclear threats have changed with Russia’s full-scale invasion of Ukraine, how to define a ‘nuclear threat’, and how NPT member states should react to nuclear threats. It sets out recommendations for how State Parties can strengthen the NPT and the nuclear taboo in the current Review Cycle.
Michael Biontino explores how the NPT can be strengthened in advance of its next review cycle. He outlines how, even in these increasingly polarised times, measures such as streamlining procedures and mechanisms, creating adequate institutional support and creating the appropriate governing structures, can all help to improve the effectiveness, efficiency, transparency, accountability, coordination, and continuity of the review process of the Treaty.
In May 2023 , the ELN and Rockefeller Brothers Fund (RBF) held a track 1.5 meeting in London featuring a range of European, American, Asian and Iranian experts to assess three possible scenarios that could come about should attempts to revive the JCPOA fail: resumption of nuclear negotiations, building regional solutions, and regional conflict. ELN Senior Associate Fellow Roxane Farmanfarmaian captures the core findings in this report.